109134 ⎘
Structure or type of the nucleic acid; Type of nucleic acid; Antisense targeting other non-coding nucleic acids, e.g. antagomirs
Pharmaceutical Composition Comprising miRNA-100 And Its Use in the Modulation Of Blood Vessel Growth and Endothelial Inflammation
#902Method for treating myocardial infarct
#903Oral delivery of therapeutically effective LNA oligonucleotides
#904Compositions and methods for diagnosing and treating melanoma
#905Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
#906Targeting microRNAs for the treatment of liver cancer
#907Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1
#908Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
#909Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
#910TREATMENT OF INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 AND TRANSCRIPTION FACTOR E3 (TFE3)
#911Method of inhibiting miR-33 using a modified oligonucleotide
#912COMPOSITIONS AND METHODS RELATED TO MIRNA IN DIABETIC CONDITIONS
#913Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBG
#914Localized Delivery of Gold Nanoparticles for Therapeutic and Diagnostic Applications
#915MicroRNA-10 antagonists and MicroRNA-10 targets for use in the treatment of a glioma
#916MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY
#917Reversible platelet inhibition
#918Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1
#919MicroRNA as a cancer progression predictor and its use for treating cancer
#920Modulation of huntingtin expression
#921Trans-acting RNA switches
#922Materials and methods useful for affecting tumor cell growth, migration and invasion
#923Minor groove binder (MGB)-oligonucleotide miRNA antagonists
#924Micro-RNA for the regulation of cardiac apoptosis and contractile function
#925Antisense oligonucleotides for inhibition of microRNA-21
#926Compositions and methods for prognosis and treatment of prostate cancer
#927Anti-miR-1 Therapy for Wound Healing
#928Methods for Diagnosing Stomach Cancer Using MicroRNA Signatures
#929Methods for Diagnosing Prostate Cancer Using MicroRNA Signatures
#930Methods for diagnosing lung cancer using MicroRNA signatures
#931Methods for diagnosing colon cancer using MicroRNA signatures
#932Methods for Diagnosing Breast Cancer Using MicroRNA Signatures
#933Methods for diagnosing stomach cancer using MicroRNAs
#934Methods for diagnosing prostate cancer using MicroRNAs
#935Methods for diagnosing pancreatic cancer using MicroRNAs
#936Methods for diagnosing lung cancer using microRNAs
#937Methods for diagnosing colon cancer using MicroRNAs
#938Methods for diagnosing breast cancer using MicroRNAs
#939Methods for diagnosing pancreatic cancer using miR-103-1, miR-103-2, miR-24-2 and miR-107
#940Methods for Diagnosing Breast Cancer Using miR-21, miR-125-1, miR-125b-2 and miR-145
#941Methods for Diagnosing Colon, Stomach, Prostate and Pancreas Cancer Using miR-223
#942Methods for Diagnosing Breast and Lung Cancer Using miR-210 and miR-213
#943Methods for diagnosing breast, colon, lung, pancreatic and prostate cancer using miR-21 and miR-17-5p
#944Treatment of inflammatory diseases using miR-124
#945CELL IMAGING METHOD FOR VIEWING MICRORNA BIOGENESIS IN THE CELLS
#946Therapeutic and diagnostic molecules
#947MicroRNA inhibitors comprising locked nucleotides
#948MicroRNA-24
#949Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)
#950TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE
#951Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#952Treatment of insulin gene (INS) related diseases by inhibition of natural antisense transcript to an insulin gene (INS)
#953CHEMICAL MODIFICATIONS MOTIFS FOR MIRNA INHIBITORS AND MIMETICS
#954Live attenuated influenza virus vaccines comprising microRNA response elements
#955Diagnosis and treatment of adrenocortical tumors using human microRNA-483
#956Treatment of 'IQ motif containing GTPase activating protein' (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP
#957Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
#958miR-31 in duchenne muscular dystrophy therapy
#959MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION
#960Treatment of Adiponectin related diseases by inhibition of natural antisense transcript to an Adiponectin
#961Aptamer that recognizes peptide
#962Lipophilic polynucleotide conjugates
#963Targeting MicroRNAs for metabolic disorders
#964Methods for enhancing utrophin production via inhibition of microRNA
#965Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#966MIRNA AND ITS TARGETS RESPECTIVELY THE PROTEINS MADE BASED ON THE TARGETS AS A PROGNOSTIC, DIAGNOSTIC BIOMARKER AND THERAPEUTIC AGENT FOR CANCER
#967Anti-MicroRNA oligonucleotide molecules
#968COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS
#969Treatment of paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1
#970Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3
#971Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2
#972Methods of modulating smooth muscle cell proliferation and differentiation
#973Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
#974Head-and-neck tumor proliferation inhibitor
#975Pharmaceutical Composition
#976Method of diagnosing poor survival prognosis colon cancer using miR-29a
#977Method of diagnosing poor survival prognosis colon cancer using miR-103-2
#978Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer
#979MODULATING IRES-MEDIATED TRANSLATION
#980Phosphodiesterase 4D7 as prostate cancer marker
#981METHOD OF PREDICTING CHEMOTHERAPY EFFECTIVENESS IN COLON ADENOCARCINOMA PATIENTS, USING MIR-21
#982Method of diagnosing poor survival prognosis colon cancer using miR-106a
#983TREATMENT OF AUTOIMMUNE INFLAMMATION USING MIR-155
#984Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#985METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF
#986Method of diagnosing poor survival prognosis colon cancer using miR-10a
#987Method of diagnosing poor survival prognosis colon cancer using miR-203
#988Method of diagnosing poor survival prognosis colon cancer using miR-16b
#989Method of diagnosing poor survival prognosis colon cancer using let-7g
#990Method of diagnosing poor survival prognosis colon cancer using miR-181b
#991Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders
#992miR-33 INHIBITORS AND USES THEREOF
#993COMPOSITIONS AND METHODS FOR MICRO-RNA EXPRESSION PROFILING OF CANCER STEM CELLS
#994Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
#995MicroRNAs In Idiopathic Pulmonary Fibrosis
#996Compositions and Methods to Treat Muscular & Cardiovascular Disorders
#997COMPOSITIONS AND METHODS RELATING TO miR-31
#998Method for inhibiting the activity of mir-155
#999Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
#1000Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome
#1001MODULATORS OF APOPTOSIS AND THE USES THEREOF
#1002MicroRNAs in Never-Smokers and Related Materials and Methods
#1003METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#1004Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
#1005TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#1006Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
#1007TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT1
#1008USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA
#1009MICRO-RNAs THAT MODULATE SMOOTH MUSCLE PROLIFERATION AND DIFFERENTIATION
#1010ANTAGONISTS OF MIR-155 FOR THE TREATMENT OF INFLAMMATORY LIVER DISEASE
#1011MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
#1012COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY
#1013Methods of modulating mesenchymal stem cell differentiation
#1014Delivery of agents using interfering nanoparticles
#1015MODULATING IMMUNE SYSTEM DEVELOPMENT AND FUNCTION THROUGH MICRORNA MIR-146
#1016CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND SMALL MOLECULES FOR USE IN REDUCING MICRO RNA ACTIVITY LEVELS AND USES THEREOF
#1017Compositions and methods for inhibition of nucleic acids function
#1018Targeting MicroRNAs For The Treatment Of Liver Cancer
#1019Method for inhibiting function of micro-RNA
#1020Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#1021Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
#1022Oligomeric compounds and compositions for use in modulation of small non-coding RNAS
#1023miR 204, miR 211, their anti-miRs, and therapeutic uses of same
#1024METHOD FOR GENERATION AND REGULATION OF IPS CELLS AND COMPOSITIONS THEREOF
#1025Uses and compositions comprising miRNAs
#1026Inhibition of angiogenesis
#1027INHIBITORY RNAS THAT REGULATE HEMATOPOIETIC CELLS
#1028ANTIDOTE OLIGOMERS
#1029Minor groove binder (MGB)-oligonucleotide miRNA antagonists
#1030miRNAs as therapeutic targets in cancer
#1031Diagnosis/Therapeutic Strategy For Gynecological Cancer by Utilizing Micro-RNA as Biomarker
#1032Anti-MicroRNA oligonucleotide molecules
#1033SMAD PROTEINS CONTROL DROSHA-MEDIATED MIRNA MATURATION
#1034Methods and compositions for reducing viral genome amounts in a target cell
#1035Viral microRNA
#1036Anti-sense microrna expression vectors
#1037METHODS FOR DIAGNOSING AND TREATING SQUAMOUS CELL CARCINOMA UTILIZING miRNA-205 AND INHIBITORS THEREOF
#1038MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#1039MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
#1040Recombinant DNA constructs and methods for controlling gene expression
#1041Recombinant DNA constructs and methods for controlling gene expression
#1042Compositions and methods for inhibiting expression of CD45 gene
#1043Modulation of T cell signaling threshold and T cell sensitivity to antigens
#1044Composition containing microRNA-21 inhibitor for enhancing radiation sensitivity
#1045Pharmaceutical compositions for treatment of HCV patients that are poor-responders to interferon
#1046Method for promoting angiogenesis, vascularization or vessel repair
#1047Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair
#1048Nucleic acid modulators of glycoprotein VI
#1049Conditionally Active Ribozymes And Uses Thereof
#1050MicromiRs
#1051Micrornas that regulate muscle cell proliferation and differentiation
#1052TARGETING OF RNA WITH EXTERNAL GUIDE SEQUENCES
#1053Anti-microRNA oligonucleotide molecules
#1054Micro-RNAs modulating immunity and inflammation
#1055MicroRNAs for inhibiting viral replication
#1056Pharmaceutical composition comprising anti-mirna antisense oligonucleotide
#1057Micro-RNA family that modulates fibrosis and uses thereof
#1058Combination treatment for the treatment of hepatitis C virus infection
#1059COMPOSITIONS AND METHODS TO TREAT MUSCULAR & CARDIOVASCULAR DISORDERS
#1060Modulation of gene expression using oligomers that target gene regions downstream of 3′ untranslated regions
#1061Screening of micro-RNA cluster inhibitor pools
#1062Micro-RNAs that control myosin expression and myofiber identity
#1063Targeting microRNAs for the treatment of liver cancer
#1064Method for inhibiting the activity of mir-155
#1065DIFFERENTIAL EXPRESSION OF MICRORNAS IN NONFAILING VERSUS FAILING HUMAN HEARTS
#1066USE OF SHORT OLIGONUCLEOTIDES FOR REAGENT REDUNDANCY EXPERIMENTS IN RNA FUNCTIONAL ANALYSIS
#1067Method of diagnosing poor survival prognosis colon cancer using microRNA-21
#1068Oligonucleotides for modulating target RNA activity
#1069Oligomeric compounds and compositions for use in modulation of pri-miRNAs
#1070MicroRNA Antisense PNAs, Compositions Comprising the Same, and Methods for Using and Evaluating the Same
#1071Method for controlling the amount of gene product, and agent for controlling the amount of gene product
#1072Recombinant DNA constructs and methods for controlling gene expression
#1073Small activating RNA molecules and methods of use
#1074OLIGONUCLEOTIDE COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#1075Treating picornavirus infection by targeting MicroRNA miR-141
#1076Chemically modified oligonucleotides
#1077Antisense RNA for treating cancer and inhibition of metastasis and vectors for antisense sequestration
#1078Pharmaceutical Composition
#1079Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1080Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1081Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1082Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1083Ligand-conjugated monomers
#1084Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
#1085MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION
#1086Use of nucleic acids with reduced pressure therapy
#1087Multifunction nanoconjugates for imaging applications and targeted treatment
#1088METHODS AND COMPOSITIONS FOR DIAGNOSING AND MODULATING HUMAN PAPILLOMAVIRUS (HPV)
#1089Compositions and methods for diagnosing and treating melanoma
#1090Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof
#1091Modulating immune system development and function through microRNA MIR-146
#1092MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS
#1093STEADY-STATE SUBCUTANEOUS ADMINISTRATION OF APTAMERS
#1094MicroRNAs
#1095Methods and compositions for regulating cell cycle progression via the miR-106B family
#1096Antisense microRNA and uses therefor
#1097Sequence-specific inhibition of small RNA function
#1098Recombinant DNA constructs and methods for controlling gene expression
#1099Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
#1100MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of solid cancers
#1101Microrna inhibition for the treatment of inflammation and myeloproliferative disorders
#1102Methods and compositions for reducing viral genome amounts in a target cell
#1103Recombinant DNA constructs and methods for controlling gene expression
#1104Modulation of T cell signaling threshold and T cell sensitivity to antigens
#1105Anti-microRNA oligonucleotide molecules
#1106Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
#1107Recombinant DNA constructs and methods for controlling gene expression
#1108Recombinant DNA constructs and methods for controlling gene expression
#1109Recombinant DNA constructs compressing engineered plant microRNAs and methods for controlling gene expression
#1110Recombinant DNA constructs and methods for controlling gene expression
#1111Recombinant DNA constructs and methods for controlling gene expression
#1112Engineered miRNA precursors for suppressing target gene expression in plants
#1113Recombinant DNA constructs and methods for controlling gene expression
#1114Recombinant DNA constructs and methods for controlling gene expression
#1115Recombinant DNA constructs and methods for controlling gene expression
#1116Recombinant DNA constructs and methods for controlling gene expression
#1117Recombinant DNA constructs and methods for controlling gene expression
#1118Recombinant DNA constructs and methods for controlling gene expression
#1119Recombinant DNA constructs and methods for controlling gene expression
#1120Recombinant DNA constructs and methods for controlling gene expression
#1121Recombinant DNA constructs and methods for controlling gene expression
#1122Recombinant DNA constructs and methods for controlling gene expression
#1123Recombinant DNA constructs and methods for controlling gene expression
#1124Recombinant DNA constructs and methods for controlling gene expression
#1125Recombinant DNA constructs and methods for controlling gene expression
#1126Recombinant DNA constructs and methods for controlling gene expression
#1127Recombinant DNA constructs and methods for controlling gene expression
#1128Recombinant DNA constructs and methods for controlling gene expression
#1129Recombinant DNA constructs and methods for controlling gene expression
#1130Methods for use in modulating miR-122a
#1131Oligomeric compounds and compositions for use in modulation of pri-mirnas
#1132Recombinant DNA constructs and methods for controlling gene expression
#1133Chemically modified oligonucleotides
#1134Methods and compositions for reducing viral genome amounts in a target cell
#1135Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#1136Sequence-specific inhibition of small RNA function
#1137Anti-microRNA oligonucleotide molecules
#1138Modified oligonucleotides for telomerase inhibition
#1139Exosomes isolated from mesenchymal stem cells and uses thereof
#1140Conjugated antisense compounds and their use
#1141Self-replicating cell selective gene delivery compositions, methods, and uses thereof